Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Canada Announces Plans to Reform Cannabis Excise Tax 2025 !!
View:
Post by 1hot-techwoman on Dec 17, 2024 8:40pm

Canada Announces Plans to Reform Cannabis Excise Tax 2025 !!

This would be Massive news for Cannabis Sector !!!! :) $$$$$

https://www.youtube.com/watch?v=fCWp8BtrM9I
Comment by QContinuum1 on Dec 18, 2024 7:57am
Unfortunately the reform proposed is not a reduction/elimination.  And given the current state of the federal finances, a reduction is unlikely anytime soon.
Comment by Hunter34 on Dec 18, 2024 3:04pm
Liberals are TAX NAZIs...Destruction of Industry is all according to plan. They will Tax all medications now...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities